Research Compliance
FWAs Part 2: Managing a Federalwide Assurance and IRB Registration
Join Advarra’s regulatory experts in another discussion of institutional and IRB responsibilities and dig deeper into the FWA topic.
Durham Nephrology Associates Enhances Reporting and Patient Experience Using CCPay
Learn how Durham Nephrology Associates implemented Advarra CCPay to enhance their clinical trial staff and patient payment process experience.
IRB Review of Phase I Research: Balancing Ethics and Efficiency
Find out how to address Phase I research challenges to enable efficient IRB review and timely study startup.
Beginner’s Guide to Minimal Risk Research
How can researchers know when research is minimal risk? Learn an overview and the regulatory flexibilities that might be eligible.
James Riddle and Barbara Schneider Delve into the Different Players Involved in Reviewing Clinical Research
In this podcast episode, we discuss the different clinical research oversight committees and functions to ensure the safety of participants.
4 Key Integrations for Your Clinical Trial Management System
Integrating your clinical trial management system enterprise-wide poses many benefits. Learn how your team can further streamline operations.
Do You Have Appropriate Oversight? Understanding the Role of DSMBs
Take a look at the role and function of independent DMCs from charter creation through interim data analysis to prepare your next trial.
Steps to Implementing a Quality Management System
This white paper outlines the full implementation process of a quality management system and how to avoid conflict by focusing on quality.
IRB Review of Social Media Recruitment and Retention Programs
Explore how existing regulations can establish best practices in using social media for clinical research participant recruitment.
Why Institutions Should Consider an Externally Administered IBC
Gene therapy clinical trials require specialized oversight & expertise. Read how institutions can prep for the boom in gene therapy research.
Beginner’s Guide to IND Safety Reporting Under 21 CFR 312(c)
Learn how to ensure compliance with FDA 21 CFR 312.32, and explore Advarra solutions that support efficient and compliant safety reporting.
Study Activation: Top Four Takeaways from Research Sites
How can sponsors leverage their relationship with their sites to ensure more efficient research?
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2024 Advarra. All Rights Reserved.